Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

FDA cites compounder for making tainted version of KV's Makena

14.03.2014 / Fierce Pharma

After the FDA approved KV Pharmaceutical's Makena in 2011, the drugmaker asked the agency to stop compounding pharmacies from making their much cheaper versions of the drug. KV filed for bankruptcy reorganization after the agency turned its back on the request, but the FDA may now be coming around.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: